New research on probiotics in the prevention and treatment of colon cancer

Histamine-producing probiotic reduces inflammation and suppresses colon tumors in mice by supplying missing enzyme, according to report

Date: September 13, 2017

Source: Elsevier

Summary:

In an innovative approach to colorectal cancer (CRC) prevention and treatment, scientists are studying ways to replace missing metabolites in patients prone to gut inflammation and CRC. A new study describes how administration of histamine-producing gut microbes to mice lacking the enzyme histidine decarboxylase (HDC) reduced inflammation and tumor formation. These results suggest that alteration of the gut microbiome with probiotics may become a new preventative or therapeutic strategy for patients at risk for inflammatory bowel disease (IBD)-associated CRC.

See more at:

https://www.sciencedaily.com/releases/2017/09/170913084437.htm